AstraZeneca has announced a landmark $2bn equity investment in Summit Therapeutics, marking a major strategic alignment between the pharmaceutical giants…
Read More
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research Study
Acute myelogenous leukemia (AML) remains one of the most formidable and aggressive malignancies in modern oncology. Characterized by rapid progression…
Read More
Daiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA Discussions
Pharmaceutical giants Daiichi Sankyo and Merck & Co., known globally as MSD, have officially announced the voluntary withdrawal of their…
Read More
Johns Hopkins Researchers Uncover How Genetic Fusions Drive Rare Kidney Cancer Through Cellular Droplet Formation
Researchers at the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins Bloomberg School of Public Health have published a…
Read More
Unlocking the Genetic Black Box: Large-Scale Study Reveals New Insights Into Feline Cancer and Human Oncology
For decades, the genetic landscape of feline cancer has remained a proverbial black box, leaving veterinarians and researchers to treat…
Read More
Revolutionary Human-Cell Bone Marrow Model Promises to Transform Blood Cancer Research and Reduce Animal Testing
Deep within the skeletal framework of the human body lies one of biology’s most industrious and tightly regulated environments: the…
Read More
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
The landscape of oncology is currently undergoing a paradigm shift as pharmaceutical giants Merck & Co. and Moderna move toward…
Read More
Cancer vaccine borrows COVID immune memory to activate T cells against tumors in mice
The global landscape of immunology has been irrevocably altered by the COVID-19 pandemic, leaving behind a massive, worldwide cohort of…
Read More
Navigating the Oncology Enrollment Funnel: Why Cancer Clinical Trials Face Protracted Timelines and High Screen Failures
The modern landscape of oncology drug development is characterized by profound scientific breakthroughs, yet it remains perpetually bottlenecked by an…
Read More
Decoding the Explosive Origins of Chronic Myeloid Leukemia: A Landmark Study Unveils Unprecedented Cancer Cell Growth Rates Years Before Diagnosis
Recent findings published in the prestigious journal Nature have fundamentally shifted our scientific understanding of chronic myeloid leukemia (CML), a…
Read More
